The major objective of the present study was to assess such a role for one particular neurotrophic factor,
These data led us to consider a role for endogenous GDNF systems in mediating some of the adaptive responses of VTA neurons to chronic administration of drugs of abuse. We present here several lines of evidence consistent with such a role. Infusion of GDNF into the rat VTA blocks biochemical and behavioral plasticity to chronic drug exposure, whereas infusion of an anti-GDNF antibody into the VTA enhances responsiveness to drugs of abuse. Behavioral responses to drug exposure are also enhanced in mice heterozygous for a null mutation in the gene that encodes GDNF. Finally, chronic drug exposure decreases levels of phosphorylated Ret in the rat VTA, which further establishes a link between endogenous GDNF signaling and drugs of GDNF and drugs of abuse, we examined the ability of GDNF, infused directly into the rat VTA, to modify biochemical adaptations to chronic drug exposure. GDNF focused on GDNF for several reasons. First, GDNF enwas delivered by osmotic minipump (at a dose of 2.5 hances the survival and maintains the differentiated g/day) through a midline cannula implanted into the properties of dopaminergic neurons in cell culture and VTA, and the ability of chronic cocaine or chronic mordoes so far more potently compared to BDNF and other phine to produce some of their characteristic biochemineurotrophins (Lin et al., 1993) . Second, GDNF dramatical changes was assessed by Western blotting. Control cally enhances the survival of midbrain dopamine neuanimals received equivalent intra-VTA infusions of vehirons in vivo after challenge with dopaminergic neurotoxcle. The results of these experiments are summarized ins such as 6-hydroxydopamine or MPTP (Beck et al.,
in Figure 1 and Tables 1 and 2 . GDNF infusion completely 1995; Kearns and Gash, 1995) . GDNF also protects aniblocked the ability of chronic morphine and chronic comals from the behavioral deficits associated with such caine to increase levels of tyrosine hydroxylase in the lesions. Strikingly, a single injection of GDNF into the VTA. GDNF infusion also blocked the ability of cocaine midbrain can exert such protective effects for at least to increase levels of the NMDAR1 glutamate receptor one month (Kearns and Gash, 1995; Winkler et al., 1996) . subunit in this brain region. (We could not assess the Third, signaling proteins for GDNF, GFR␣1 and the assoeffect of GDNF on drug regulation of neurofilament prociated protein tyrosine kinase Ret, are both highly enteins and glial fibrillary acidic protein, since surgery itself riched in midbrain dopamine neurons (Treanor et al., alters levels of these proteins as we reported previously 1996; Trupp et al., 1996, 1997, 1998) . The binding of [Berhow et al., 1995] .) Interestingly, infusion of GDNF GDNF to its receptor complex causes the phosphorylainto the VTA also blocked the ability of chronic cocaine tion and activation of Ret, which then mediates the physiological effects of the neurotrophic factor. exposure to produce characteristic biochemical changes Vehicle ϩ Sham, animals received intra-VTA infusions of vehicle plus implantation of sham pellets; Vehicle ϩ Morphine, animals received intra-VTA infusions of vehicle plus implantation of morphine pellets; GDNF ϩ Morphine, animals received intra-VTA infusions of GDNF plus implantation of morphine pellets. In the top-row experiment, intra-VTA infusion of GDNF was initiated 2 days before the start of morphine treatment and continued concurrently throughout morphine treatment; in the bottom-row experiment, infusion of GDNF was initiated 2 days after the completion of morphine treatment (see Experimental Procedures). VTA extracts were subjected to Western blotting for tyrosine hydroxylase. GDNF infusions alone had no effect on tyrosine hydroxylase levels (see Table 2 ). We next studied the effect of intra-VTA administration showed no untoward effects of the neurotrophic factor: of GDNF on behavioral responses to cocaine. Rats retheir weights were equivalent to those of vehicle-injected ceived continuous infusions of GDNF (2.5 g/day) into controls, and the animals showed no gross behavioral the VTA via osmotic minipump as in the biochemical abnormalities.
experiments and were tested in a place-conditioning The ability of GDNF to attenuate biochemical adaptaparadigm, in which animals learn to associate an envitions to chronic drug exposure shows regional specificronment paired with drug exposure. Place conditioning ity. Infusion of GDNF into the nearby substantia nigra is, therefore, considered a measure of the rewarding (another dopamergic nucleus that is located just lateral properties of a drug. Figure 3 shows the effect of GDNF to the VTA) failed to have the effect of the intra-VTA on place conditioning to cocaine. In both GDNF-and infusions: cocaine's ability to induce biochemical adapvehicle-infused animals, cocaine established place preftations in the VTA was unaffected by intranigral infusions erences in a dose-dependent manner. However, GDNFof GDNF (data not shown).
infused animals showed reduced preferences at all Induction of tyrosine hydroxylase is one of the most doses studied, indicating that GDNF reduces an anirobust findings with chronic drug exposure and was, as mal's sensitivity to the rewarding activity of cocaine. a result, used to study the dose response to GDNF action. In this experiment, we administered GDNF via a single injection into the rat VTA, based on the reported ability of this route of administration to protect midbrain dopamine neurons from neurotoxic lesions (Kearns and Gash, 1995; Winkler et al., 1996) . The results are shown in Figure 2 . The lowest dose of GDNF tested, 0.3 g, had no detectable effect on the ability of chronic morphine to induce tyrosine hydroxylase in this brain region. Moderate doses of GDNF, like the continuous infusion of the neurotrophic factor, antagonized morphine's effect on tyrosine hydroxylase without influencing basal levels of the enzyme. Still higher doses (10 g) decreased levels of tyrosine hydroxylase in the VTA and prevented any induction by morphine.
The experiments described above show that concomitant exposure to GDNF can prevent the ability of morphine or of cocaine to induce characteristic biochemical adaptations in the VTA-NAc pathway. It also was of interest to determine whether infusion of GDNF into the sions of GDNF, which demonstrates the ability of GDNF 
Infusion of Anti-GDNF Antibody into the VTA: Biochemical and Behavioral Effects
The results obtained with intra-VTA infusions of GDNF showed that exogenous GDNF can modify the biochemical and behavioral responses to chronic drug exposure. of cocaine had no effect on tyrosine hydroxylase levels in animals treated with the inactive antibody. Neither antibody altered levels of tyrosine hydroxylase in the VTA in the absence of cocaine exposure (data not Intra-VTA infusion of active antibody enabled a threshold dose of cocaine to establish a significant place prefshown).
Infusion of the active anti-GDNF antibody similarly erence, whereas animals that received intra-VTA infusions of inactive antibody or of vehicle showed no effect increased an animal's sensitivity to the behavioral effects of cocaine in the place-conditioning paradigm.
( Figure 4B ).
GDNF Knockout Mice: Behavioral and Biochemical Effects
As a complementary way to examine the influence of endogenous GDNF pathways on drug responsiveness, we studied behavioral responses to cocaine in GDNF knockout mice. Since homozygote knockouts die shortly after birth from renal complications (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996), we used heterozygote knockouts that appear normal and do not show this lethality. Wild-type littermates were used as controls. The mice were studied first in a place-conditioning paradigm. As shown in Figure 5A , cocaine established place preferences in wild-type mice in a dose-dependent manner, with significant preferences seen at a higher dose of cocaine (10 mg/kg), but not at a lower dose (5 mg/kg). In contrast, GDNF knockout mice developed high levels of place conditioning to both doses. These results indicate greater responsiveness of the knockouts to the rewarding effects of cocaine. Mice were studied next in a locomotor activity paradigm. Wild-type and GDNF knockout mice did not differ in their locomotor response when first placed in the locomotor chamber, and they showed equivalent habituation in locomotor activity after repeated exposures to the chamber (data not shown). As shown in Figure 5B , wild-type and knockout mice also showed equivalent locomotor activation in response to the initial injection of cocaine. However, GDNF knockout mice showed significantly greater increases in locomotor activity following repeated exposures to cocaine, a phenomenon termed locomotor sensitization.
GDNF knockout mice also exhibited biochemical differences, compared to their wild-type littermates, in the mesolimbic dopamine system. The knockouts showed dramatically elevated levels of ⌬FosB in the NAc (289 Ϯ are mediated via blockade of the protein kinase A upregulation in this brain region. The behavioral consequences of GDNF's ability to block the drug-induced assay, we found that chronic administration of cocaine biochemical adaptations in the VTA (e.g., induction of or of morphine caused a robust decrease in levels of tyrosine hydroxylase and NMDAR1) remain unknown, phosphoRet by 65% and 72%, respectively, in the rat since these adaptations have not yet been related di-VTA ( Figure 6B ). In contrast, no effect was seen in the rectly to behavioral plasticity. Nevertheless, the fact that nearby substantia nigra after chronic cocaine (phos-GDNF blocks behavioral responses to drug exposure phoRet, 93% Ϯ 23% of sham Ϯ SEM; total Ret, 96% Ϯ means that the net effect of the neurotrophic factor must 19% of sham; N ϭ 6-7) or chronic morphine (data not involve biochemical changes that oppose drug action. shown).
The contrast between the effects of GDNF and BDNF on actions of drugs of abuse is interesting. Intra-VTA Discussion infusions of BDNF, like those of GDNF, in rats block some of the biochemical adaptations to morphine and The major findings of this study are that exogenous cocaine, for example, induction of tyrosine hydroxylase GDNF, administered directly into the rat VTA, blunts in the VTA and of protein kinase A in the NAc (Berhow both biochemical and behavioral adaptations to reet al., 1995). Yet, a recent study showed that BDNF peated administration of drugs of abuse. The study also dramatically augments an animal's responses to the loestablishes that endogenous GDNF systems are recomotor and rewarding properties of cocaine (Horger et quired for normal biochemical and behavioral responses al., 1999). Such augmented behavioral responses would to drug exposure: infusion of anti-GDNF antibody dimake sense if the biochemical adaptations blocked by rectly into the VTA increases a rat's sensitivity to drug BDNF are homeostatic; that is, they serve to reduce effects, and mice that lack one copy of the GDNF gene further drug effects. Presumably, these findings indicate show a similar increase in drug sensitivity. This is a that the net effect of BDNF, in contrast to that of GDNF, involves biochemical changes that increase behavioral particularly important observation because it extends responses to drug exposure. Consistent with this interThe findings that GDNF blocks the drug-induced pretation is the finding that BDNF knockout mice, in upregulation of tyrosine hydroxylase in the VTA and contrast to GDNF knockout mice, show reduced beblocks behavioral responses to drugs of abuse may havioral plasticity to repeated cocaine administration seem surprising given that GDNF is generally believed (Horger et al., 1999) . The biochemical endpoints examto enhance, rather than oppose, the dopaminergic pheined in the present study and in the earlier studies of notype. However, direct measures of the effect of GDNF BDNF likely represent only a small portion of the adaptaon dopamine levels in the substantia nigra and striatum tions that chronic drug administration causes in the VTA have yielded mixed results. For example, in lesion studand NAc. Therefore, a major goal of future research is ies GDNF rescues toxin-induced decreases in tyrosine to further characterize the influence of GDNF and BDNF hydroxylase and tissue dopamine levels and in cell culon the mesolimbic dopamine system, with the objective ture enhances the survival of dopamine neurons (e.g., of finding differences in the molecular and cellular ac- 
of this brain region (see Experimental Procedopamine neurons is that GDNF might promote a produres), produces effects opposite to that of locallygram of gene expression that supports homeostatic or applied GDNF. This hypothesis would then suggest that reparative processes in the neurons at the expense of the ability of GDNF to modify drug-induced adaptations proteins (like tyrosine hydroxylase) that reflect the neu-(e.g., induction of ⌬FosB, protein kinase A) in the NAc, rons' highly differentiated state (see Cheah and Geffen, which itself appears to lack GFR␣1 and Ret, occurs 1973; Grafstein, 1975). indirectly via the neurotrophic factor's actions in the
One of the most important aspects of the present VTA. This is consistent with the evidence that induction study is the evidence for a role of endogenous GDNF of ⌬FosB in the NAc in response to chronic cocaine systems in drug action. We show that disruption of enadministration can be blocked by a dopamine receptor dogenous GDNF (via anti-GDNF antibody or a genetic antagonist (Nye et al., 1995) . knockout of GDNF) augments drug responsiveness. We A major question raised by the present study emerges: also show that while chronic drug exposure does not what are the mechanisms by which GDNF opposes bioalter levels of expression of GDNF, GFR␣1, or Ret in the chemical adaptations to chronic morphine or chronic mesolimbic dopamine system, it does cause a dramatic cocaine exposure? The fact that GDNF exerts these decrease in GDNF signaling as evidenced by a 65%-effects with two structurally divergent drugs makes it 70% reduction in levels of tyrosine-phosphorylated Ret highly unlikely that an idiosyncratic chemical interaction in the VTA. Such phosphorylation of Ret is known to between GDNF and drug is involved. The postreceptor reflect its state of activation and to mediate the physiosignaling pathways by which GDNF produces its physiological effects of GDNF and GFR␣1 (Treanor et al., 1996; logical effects remain poorly understood. It is known Trupp et al., 1996) . Taken together, these findings supthat GDNF produces its effects through GFR␣1 and the port the scheme that the drug-induced decrease in protein tyrosine kinase Ret. However, subsequent steps GDNF signaling in the VTA removes a homeostatic feedin this signaling pathway have not been established. back (or counteracting) mechanism on this neural pathSimilarly, the mechanisms by which chronic exposure way and thereby contributes to sensitized biochemical to a drug of abuse causes the observed biochemical and behavioral responses to drugs of abuse. It will be changes in the VTA (e.g., adaptations in tyrosine hydroxinteresting in future studies to determine the precise ylase, NMDAR1, and neural and glial filaments) are unmechanism by which chronic drug administration deknown. It will be interesting in future studies to identify creases phosphoRet levels specifically within this brain the precise molecular steps at which cross-talk between region. drug-regulated and GDNF-regulated signaling pathTo conclude, the results of the present study establish ways converge. The mechanisms of convergence may a functional interaction between GDNF and drugs of be quite complex. For example, chronic morphine and abuse at the level of the mesolimbic dopamine system. cocaine appear to increase levels of tyrosine hydroxyThe findings highlight the complex types of mechanisms lase immunoreactivity in the VTA via a posttranscripthat are likely induced in the brain by chronic exposure to tional mechanism (Boundy et al., 1998), whereas GDNF, a drug of abuse. The involvement of GDNF and perhaps at least at higher doses, appears to decrease tyrosine other neurotrophic factor systems in drug-induced neuhydroxylase gene transcription in this brain region (Mesral and behavioral plasticity could be particularly imporser et al., 1999). This action of GDNF provides one plausitant for the very long-lived changes in brain function ble mechanism, at the molecular level, by which such associated with addiction. These results also raise the cross-talk between GDNF and drugs of abuse may occur.
interesting possibility that medications targeted to chronic morphine treatment as described above. Two days after GDNF or to its signaling pathway could be useful as the last pellet implantation, the animals underwent surgery for initianovel treatment agents for addictive disorders in humans.
tion of intra-VTA infusions. The animals were used 7 days later.
Experimental Procedures Western Blotting
Immunolabeling of tyrosine hydroxylase and ⌬FosB (Hiroi et al., Intra-VTA Surgery 1997), NMDAR-1 (Fitzgerald et al., 1996) , and PKA-catalytic subunit Male Sprague-Dawley rats (CAMM, Wayne, NJ), weighing 250-300 (Lane-Ladd et al., 1997) were performed as described elsewhere. g at the start of the experiment, were used in this study. GDNF Briefly, brains were removed rapidly from decapitated rats and (Amgen) infusion or infusion of an anti-GDNF antibody (see below; chilled in ice-cold physiological buffer. For rats, VTA and NAc were Amgen) involved the implantation of osmotic minipumps (Alzet), obtained from coronal brain slices using either a 15G syringe needle which provide a constant infusion rate of 0.5 l/hr for up to 10 days, (for all VTA punches and for NAc punches used to analyze PKA) or connected to a midline intra-VTA cannula (Berhow et al., 1995) . a 12G syringe needle (for all other NAc punches). For mice, VTA GDNF or anti-GDNF antibody was delivered in a vehicle solution and NAc punches were obtained by use of a 16G and 15G syringe consisting of 10 mM sodium phosphate (pH 7.4), 0.9% NaCl, and needle, respectively. Brain samples were homogenized in 1% SDS. 1% bovine serum albumin.
Protein determinations were made using the method of Lowry. BeThe GDNF concentration in the minipump was calculated to result tween 5 g and 50 g of protein were loaded onto SDS-polyacrylin a delivery of 2.5 g GDNF per day. This dose was chosen for two amide gels and subjected to electrophoresis. reasons. First, this dose was on the low end of doses of GDNF that
The following antibodies were used: a rabbit anti-FRA (Fos-related have been shown to be effective at preventing the degeneration of antigen) antibody for ⌬FosB (1:4,000, M. J. Iadarola, National Instisubstantia nigra dopaminergic neurons after a neurotoxic lesion (Lu tutes of Health, Bethesda, MD); a rabbit anti-tyrosine hydroxylase and Hagg, 1997). Second, this dose was also near the low end of antibody (1:10,000, EugeneTech, Allendale, NJ); a rabbit antithe dose range of other neurotrophic factors that have been shown NMDAR1 antibody (1:5,000, S. F. Heinemann, La Jolla, CA); a rabbit to be biochemically and behaviorally active when administered into anti-protein kinase A-C␣ antibody (1:1,000, Santa Cruz Biotechnolthe VTA (Berhow et al., 1995 . ogy, Santa Cruz, CA), which recognizes both the ␣ and ␤ forms of Two anti-GDNF antibodies were used in this study: G90 (Amgen), the catalytic subunit (Lane-Ladd et al., 1997); and a goat anti-Ret which is known to block GDNF action in vitro, and 1531 (Amgen), antibody (1 g/ml, antibody C-20, Santa Cruz Biotechnology). Prowhich does not block anti-GDNF action in vitro (Xu et al., 1998).
teins were detected using horseradish peroxidase-conjugated IgG However, the two antibodies are equivalent in terms of their ability (1:2,000, Vector, Burlingame, CA) followed by chemiluminescence to detect GDNF in immunoassays. The antibodies were loaded into (Dupont NEN, Boston, MA). Equal loading and transfer of proteins minipumps at a concentration sufficient to yield a delivery of 240 was confirmed by the following: (1) all blots were stained with amido ng of antibody per day. Immunohistochemical staining of brains black; (2) levels of several other proteins (e.g., neurofilament proafter such antibody infusions demonstrated no detectable diffusion teins, glial fibrillary acidic protein) were not altered by the drug and of the antibodies beyond the injected area (VTA).
GDNF treatments used; and (3) the same blots used to measure The implantation surgery technique used for this study is deproteins that are drug regulated (e.g., tyrosine hydroxylase) were scribed elsewhere (Berhow et al., 1995) . Briefly, animals were anesalso used to measure levels of these other proteins that were not thetized with 50 mg/kg pentobarbital supplemented with atropine drug regulated. Levels of immunoreactivity were quantified on a (0.25 ml/kg) and implanted with an osmotic pump connector cannula Macintosh-based image analysis system and were linear over at (28G cannula, 22G connector; Plastic Products Company). The coorleast a 3-fold range of tissue concentration used. Levels of protein dinates used were for the midline of the VTA (AP Ϫ5.3 mm, DV 8.4
in experimental samples were compared with those of controls; mm). In one experiment, cannulae were placed in the substantia statistical analyses were performed by use of a Student's t test. nigra with the following coordinates: AP Ϫ5.3 mm, DV 7.2 mm, and ML Ϯ 3.0 mm. Osmotic pumps were placed subcutaneously between the scapulae and connected to the cannula with PE60
Assay for PhosphoRet tubing (Clay Adams). The tubing was secured at both ends by LocGiven the lack of availability of phospho-specific anti-Ret antibodies Tite, and the cannula was sealed in place using dental cement that are suitable for brain extracts, we developed an alternative mounted to four skull screws. After the cement dried, animals were method to assay levels of tyrosine-phosphorylated Ret. Like many sutured, treated with antiseptic, and left under observation on a protein tyrosine kinases that function as transmembrane receptors, heating pad until they revived.
Ret expression is relatively low in brain and difficult to measure in In some experiments, GDNF (0.3-10 g) was administered directly crude extracts without an initial partial purification step. Since Ret into the VTA as a single injection via a Hamilton syringe. The GDNF has been shown to undergo N-linked glycosylation ( press Ret. Ret-enriched extracts were then subjected to immunoprecipitation with anti-phosphotyrosine antibody followed by In all cocaine experiments, animals underwent surgery for implantation of intra-VTA cannula on day 1. Intra-VTA infusions of vehicle immunoblotting for Ret to obtain a final measure of tyrosine-phosphorylated Ret in brain samples. or GDNF were initiated at this time. Cocaine injections were initiated the day after surgery and were given daily for 5-7 days. For biochem-VTA and substantia nigra punch dissections were obtained from control and morphine-treated rats as described above, except that ical experiments, animals were used either 6 or 16 hr after the last cocaine injection. In all morphine experiments, unless stated otherthe dissection buffer contained 1 mM NaVO 4 , an inhibitor of protein tyrosine phosphatases. Frozen punches were sonicated in a buffer wise, animals underwent surgery for initiation of intra-VTA infusions or injections on day 1. Morphine pellets were implanted daily for 5 containing 1% sodium dodecyl sulfate, 20 mM HEPES (pH 7.4), 100 mM NaCl, 1 mM NaVO 4 , 50 mM NaF, 10 mM sodium pyrophosphate, days beginning on day 3. The animals were used the day after the last pellet implantation. In some experiments, animals first received 20 g/ml leupeptin, 10 g/ml pepstatin A, 10 g/ml aprotinin, and 1 mM phenylmethylsulfonylfluoride. Aliquots of brain samples (condays. On days 2, 4, and 6, mice received a saline injection and were confined to one of the side chambers. On days 3, 5, and 7, mice taining 150 g of protein) were diluted 10-fold with sonication buffer with 2% Triton X-100 instead of sodium dodecyl sulfate. Forty microreceived an injection of cocaine and confined to the other side of the chamber. liters of wheat germ agglutinin-sepharose CL4B beads (Sigma) were added to each sample and incubated for 4 hr at 4ЊC. Resulting On day 8, the animals were allowed to freely explore the entire apparatus, and the time spent in each side was again recorded. pellets were washed extensively with ice-cold Triton-X 100 buffer. Glycosylated proteins were then eluted in 250 l of the Triton-X This procedure has been shown to produce reliable measures of place conditioning in mice (Hiroi et al., 1997) . 100 buffer containing 0.3 M N-acetylglucosamine and omitting the sodium pyrophosphate. Two micrograms of anti-phosphotyrosine Place-conditioning data are reported as the percent change in time spent on the drug-paired side. This is calculated by comparing antibody (PY20, BD Transduction Laboratories, Lexington, KY) was added to each eluate, and the mixtures were incubated overnight the amount of time each animal spent in the drug-paired chamber before and after conditioning. at 4ЊC. The antibody complexes were precipitated using Protein G-sepharose beads. Pellets were washed extensively with Triton Locomotor activity and sensitization in mice were measured exactly as described (Hiroi et al., 1997) . Briefly, mice were tested at X-100 buffer without sodium pyrophosphate and then subjected to Western blotting with the anti-Ret antibody described above except the same time each day. The locomotor activity chamber was a plastic cage (28 ϫ 17 ϫ 12 cm) with ten pairs of photocell beams, that ECL-plus (Amersham) was used for chemiluminescent detection.
which divided the box into eleven rectangular fields. Horizontal movement was counted as locomotor activitiy. For the first 3 days Several controls were performed to validate this assay. Ret was not detectable in supernatants of wheat germ agglutinin-treated (habituation), mice were placed into the chambers immediately after saline injections and locomotor activity was measured for 10 min. samples, which confirms complete recovery of Ret by this method. Ret was also not detectable in samples precipitated by wheat germ From days 4-7, mice were given cocaine injections and placed in the chambers for 10 min. 
